Zhejiang NHU Soars 8.07%, Hits Intraday High of CNY 36.38

Zhejiang NHU Co. has experienced significant activity today, marking an impressive gain of 8.07% as of March 6, 2026. The stock reached an intraday high of CNY 36.38, reflecting strong performance metrics that distinguish it within the Pharmaceuticals & Biotechnology sector. Over the past year, Zhejiang NHU has generated a remarkable return of 67.13%, significantly outperforming the China Shanghai Composite, which recorded a gain of 21.98%. The company's robust financial health is underscored by a return on equity (ROE) of 24.27% and a favorable price-to-book ratio of 2.39. Additionally, the firm has reported positive results for five consecutive quarters, with profits soaring by 116.6% during the same period. Zhejiang NHU's operating cash flow reached its highest at CNY 8,214.79 million, while its debt-equity ratio stands at a low -4.26%. The company has also seen a decrease in raw material costs by 5.1% year-over-year, contributing to its strong financial position. With a market capitalization of CNY 89,895 million, Zhejiang NHU continues to solidify its status as a key player in the market.